Results 141 to 150 of about 71,616 (291)

Real‐world outcomes of zavegepant use in a tertiary care setting using the Migraine Treatment Optimization Questionnaire‐5

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn, Bradley Ong, Harpreet Kaur, Roman Popov, Claire Sonneborn, Aarushi Suneja   +5 more
wiley   +1 more source

Calcitonin

Journal of the Royal College of Physicians of London, 1968
openaire   +2 more sources

Followup Results of a Combination of Calcitonin Gene-Related Peptide and Prostaglandin E1 in the Treatment of erectile Dysfunction. [PDF]

, 1993
Kuczyk, M., Stief, Christian Georg, Mohamad Djamilian, Markus Kuczyk, Jonas, Udo, Christian G. Stief, Djamilian, Mohamad H., Udo Jonas   +7 more
core   +1 more source

Responding With Evidence and Access for Childhood Headaches (REACH) study: A comparative effectiveness trial of cognitive behavioral therapy monotherapy versus combined cognitive behavioral therapy–pharmacotherapy with amitriptyline for the prevention of childhood migraine—The study protocol

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Migraine is one of the most common chronic health problems in children and adolescents, resulting in high levels of functional disability. Symptoms frequently persist into and impact the course of adulthood for affected individuals. Current practice recommendations include a combined therapy approach of preventive medication and cognitive ...
Estée C. H. Feldman, Michelle M. Ernst, Maya A. Marzouk, Robert C. Gibler, Brooke L. Reidy, Leigh A. Chamberlin, Megan Kirschman, James Peugh, Marielle Kabbouche, Susan L. LeCates, Joanne Kacperski, Jessica A. Saunders, Andrew D. Hershey, Marcy E. Yonker, Christina L. Szperka, Amy A. Gelfand, Scott W. Powers, on behalf of the REACH Study Investigators, Joanne Kacperski, Jennifer McVige, Frank Berenson, Chaouki Khoury, Judy Adelizzi‐Delany, Marcy Yonker, Elizabeth Ackley, J. Ivan Lopez, Ann Pakalnis, Sara Pavitt, Scott Turner, Elizabeth Doll, Michael Sowell, Rachel Evans, Lauren Evanczyk, Reena Rastogi, Amy Gelfand, Hannah Shapiro, Christina Szperka, Ankita Gosh, Rashmi Rao   +38 more
wiley   +1 more source

Personalized machine learning prediction of next‐day migraine persistence using digital headache diary data

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Migraine is a disabling neurological disorder with substantial interindividual variability. Predicting whether an ongoing migraine attack will persist into the following day remains challenging. We evaluated the feasibility and predictive performance of personalized machine learning models for predicting next‐day migraine
Ya‐Hsiu Tsai, Chen‐Lin Chiou, Jun‐Jun Lee, Chun‐Ming Yang, Kao‐Chang Lin, Tain‐Junn Cheng, Ja‐Hwung Su, Cheng‐Hsin Chuang   +7 more
wiley   +1 more source

Targeted liquid chromatography–tandem mass spectrometry profiling of arginine and histidine derivatives in chronic migraine: Discriminatory performance and changes after onabotulinumtoxinA therapy

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary People with chronic migraine may have changes in amino‐acid metabolism, but it remains unclear which metabolic pathways are associated with the disease and early response to onabotulinumtoxinA treatment. We measured plasma amino‐acid levels in patients with chronic migraine and healthy controls and assessed changes after 1 month ...
Seyma Dumur, Kadidiatou Diarra, Joudy Sewidan, Julie Jalila Kalmoni, Demet Aygun, Dildar Konukoglu, Hafize Uzun   +6 more
wiley   +1 more source

The Expression of Neuropeptides in Pulpitis: A Systematic Review and Meta‐Analysis

International Endodontic Journal, EarlyView.
ABSTRACT Background Neuropeptides play key roles in the inflammatory, nociceptive and reparative processes of the dental pulp. Their upregulation has been frequently observed in inflamed pulps, suggesting potential diagnostic value supporting a role for neurogenic inflammation in symptomatic irreversible pulpitis.
N. Watson, D. Edwards, Q. Vuong, I. Obara   +3 more
wiley   +1 more source

Scalp Dysesthesia: Emerging Pathophysiologic Insights and Therapeutic Implications

International Journal of Dermatology, EarlyView.
Scalp dysesthesia is a chronic condition diagnosed through exclusion. This scoping review synthesized data from 59 patients to identify recurrent clinical features, comorbidities, and management strategies that may support earlier diagnosis. Emerging patterns suggest that neuronal sensitization may underlie common symptoms.
Aditya K. Gupta, Jaspreet Kaur, Amanda Liddy, Paradi Mirmirani, Vincent Piguet   +4 more
wiley   +1 more source

How to manage medullary thyroid carcinoma: current treatment strategies. [PDF]

Drugs Context
Saltiki K, Karapanou O, Michalaki M, Effraimidis G.   +3 more
europepmc   +1 more source

Intracavernous Calcitonin-gene Related Peptide Plus Prostaglandin E 1. Possible Alternative to Penile Implants in Selected Patients. [PDF]

, 1994
Kuczyk, M., Armin J. Becker, Walter F. Thon, Thon, Walter F., Jonas, Udo, Christian G. Stief, Truss, Michael C., Becker, Armin J., Stief, Christian Georg, Michael C. Truss, Markus Kuczyk, Mohamad H. Djamilian, Djamilian, Mohamad H., Udo Jonas   +13 more
core   +1 more source